LP21309-7
Didanosine
Active
Descriptions
A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by a hydrogen. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. Didanosine is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA by binding to reverse transcriptase; ddI is then metabolized to dideoxyadenosine triphosphate, its putative active metabolite. Source: National Library of Medicine, MeSH 2006
Didanosine is a Nucleoside Reverse Transcriptase Inhibitor(NRTI) antiretroviral drug used in the treatment of HIV. Drug resistance reports assist with treatment decisions. Source: Regenstrief Institute
Basic Part Properties
- Part Display Name
- Didanosine
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2001-01-02
- Construct for LOINC Short Name
- Didanosine
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=LP21309-7 - ConceptMap translate
- https:
//fhir.loinc.org/ConceptMap/$translate?system=http: //loinc.org&code=LP21309-7
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| zh-CN | Chinese (China) | 去羟肌苷 Synonyms: ddI; |
| fr-CA | French (Canada) | Didanosine |
| et-EE | Estonian (Estonia) | Didanosiin |
| es-ES | Spanish (Spain) | Didanosina |
| it-IT | Italian (Italy) | Didanosina |
| tr-TR | Turkish (Turkey) | Didanozin |
| ru-RU | Russian (Russian Federation) | Диданозин |
| nl-NL | Dutch (Netherlands) | didanosine |
| fr-BE | French (Belgium) | Didanosine |
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright